Roche flags 2023 earnings decline on slump in COVID products Ruchika Sharma3 Feb 2023 11:21 AM ISTAnalysts have said that market confidence in Roche's drug development abilities, previously among the highest in the industry, has taken a blow from...
Roche gets European Commission nod for Xofluza to treat influenza in children aged one year and above Ruchika Sharma17 Jan 2023 12:15 PM ISTInfluenza is a serious infectious disease and represents a significant threat to public health.
Roche gets USFDA priority review for Glofitamab to treat relapsed or refractory large B-cell lymphoma Ruchika Sharma7 Jan 2023 2:30 PM ISTGlofitamab is an investigational CD20xCD3 T-cell-engaging bispecific antibody designed to target CD3 on the surface of T-cells and CD20 on the surface...
Submit Phase IV CT protocol for Entrectinib: CDSCO panel tells Roche India Dr. Divya Colin2 Jan 2023 5:45 PM ISTNew Delhi: Rejecting the drug major Roche's alternative proposal to the Phase IV clinical trial of anti-cancer Entrectinib capsules of 100 mg and 200...
Roche bags USFDA approval for Lunsumio to treat follicular lymphoma Ruchika Sharma24 Dec 2022 2:00 PM ISTFollicular lymphoma (FL) is the most common slow-growing (indolent) form of non-Hodgkin lymphoma, accounting for about one in five cases.
Patent infringement: Roche loses US appeal in Sandoz lung disease drug case Ruchika Sharma24 Dec 2022 11:30 AM ISTSan Francisco-based Genentech's Esbriet is used to treat IPF, a serious chronic lung disease. Roche earned over $1 billion last year from worldwide...
Roche Actemra gets USFDA okay to treat COVID in hospitalised adults Ruchika Sharma22 Dec 2022 11:15 AM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Actemra (tocilizumab) intravenous (IV) for the treatment of...
CHMP recommends expansion of EU label for Roche Hemlibra to include people with moderate haemophilia A Ruchika Sharma18 Dec 2022 12:00 PM ISTHemlibra is approved as a treatment for people with haemophilia A with factor VIII inhibitors in more than 110 countries worldwide and for people...
Submit Phase IV CT protocol: CDSCO Panel tells Roche over Anti-Cancer drug Pralsetinib Dr. Divya Colin16 Dec 2022 6:00 PM ISTNew Delhi: Reiterating the earlier recommendation regarding the condition of conduct a Phase IV clinical trial of anti-neoplastic drug Pralsetinib,...
Roche Pharma CEO Bill Anderson to step down Ruchika Sharma12 Dec 2022 3:30 PM ISTAnderson will be replaced on a temporary basis by Thomas Schinecker, the current head of diagnostics who is due to become group CEO on March 14.
Roche Alzheimer's disease Cerebrospinal Fluid assays get USFDA clearance Ruchika Sharma11 Dec 2022 12:00 PM ISTThe Elecsys AD CSF assays achieve 90% concordance with the Amyloid PET scan imaging.
Roche to stop all Gantenerumab studies in early Alzheimer's disease Ruchika Sharma2 Dec 2022 2:30 PM ISTRoche is still testing a different formulation of gantenerumab called trontinemab, designed to ferry the drug across the blood brain barrier -...
